CDMRP Peer Reviewed Medical Research Program: Investigator Initiated Award

The PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the PRMRP Topic Areas. 

The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician's first-hand knowledge of patients, or anecdotal data. Applications must include relevant data that support the rationale for the proposed study. These data may be unpublished or from the published literature.

FY23 PRMRP Topic Areas

Autoimmune Disorders and Immunology

• Celiac Disease

• Eczema

• Food Allergies

• Guillain-Barre Syndrome

• Inflammatory Bowel Disease

• Neuroinflammatory Responses to Emerging Viral Diseases

• Proteomics

• Rheumatoid Arthritis

• Scleroderma

Cardiovascular Health

• Familial Hypercholesterolemia

• Hypercholesterolemia

• Proteomics

• Vascular Malformations

Hemorrhage Control and Blood Products

• Hemorrhage Control

• Proteomics

• Trauma

Infectious Diseases

• Hepatitis B

• Malaria

• Neuroinflammatory Responses to Emerging Viral Diseases

• Proteomics

• Tuberculosis

Internal Medicine

• Endometriosis

• Focal Segmental Glomerulosclerosis

• Interstitial Cystitis

• Lymphatic Disease

• Lymphedema

• Nephrotic Syndrome

• Pancreatitis

• Polycystic Kidney Disease

• Pressure Ulcers

• Proteomics

Neuroscience

• Eating Disorders

• Maternal Mental Health

• Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome

• Neuroactive Steroids

• Neuroinflammatory Responses to Emerging Viral Diseases

• Non-Opioid Therapy for Pain Management

• Peripheral Neuropathy

• Proteomics

• Sleep Disorders and Restriction

• Suicide Prevention

• Trauma

Orthopaedic Medicine

• Arthritis

• Orthopaedics

• Proteomics

• Trauma

Rare Diseases and Conditions

• Dystonia

• Ehlers-Danlos Syndrome

• Epidermolysis Bullosa

• Fibrous Dysplasia/McCune-Albright Syndrome

• Fragile X

• Frontotemporal Degeneration

• Hereditary Ataxia

• Hydrocephalus

• Mitochondrial Disease

• Myotonic Dystrophy

• Proteomics

• Sickle-Cell Disease

• Von Hippel-Lindau Syndrome Benign Manifestations

Respiratory Health

• Proteomics

• Pulmonary Fibrosis

• Respiratory Health

• Trauma

It is expected that 20 awards will be granted this year. 

Funding: $1,600,000 ($2,000,000 if partnering)
Duration: 4 years

Research authority due date: 13.4.23

LOI (required) due date: 19.4.23
Full proposal due date:31.5.23